These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6175565)

  • 21. Macrophage antitumor activity in vitro. Comparative analysis of cytolytic, cytostatic, and cytotoxic activities of mouse macrophages and human monocytes.
    Soldateschi D; Censini S; de Gori V; Antoni G; Tagliabue A; Boraschi D
    Immunobiology; 1984 May; 166(3):251-62. PubMed ID: 6376332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage antitumor activity: impaired responsiveness to interferon-gamma of macrophages from genetically defective mice.
    Boraschi D; Censini S; Tagliabue A
    Eur J Immunol; 1984 Nov; 14(11):1061-3. PubMed ID: 6437846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement for protein synthesis for induction of macrophage tumoricidal activity by IFN-alpha and IFN-beta but not by IFN-gamma.
    Blasi E; Herberman RB; Varesio L
    J Immunol; 1984 Jun; 132(6):3226-8. PubMed ID: 6725951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of macrophage responsiveness to platelet-activating factor by interferon-gamma and lipopolysaccharide.
    Howard AD; Erickson KL
    Cell Immunol; 1996 Dec; 174(2):155-64. PubMed ID: 8954615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
    Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
    J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms.
    Redmond HP; Shou J; Gallagher HJ; Kelly CJ; Daly JM
    J Immunol; 1993 Apr; 150(8 Pt 1):3427-33. PubMed ID: 8385685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage function in simian AIDS. Killing defects in vivo are independent of macrophage infection, associated with alterations in Th phenotype, and reversible with IFN-gamma.
    Brodie SJ; Sasseville VG; Reimann KA; Simon MA; Sehgal PK; Ringler DJ
    J Immunol; 1994 Dec; 153(12):5790-801. PubMed ID: 7989775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of macrophage-mediated cytotoxicity: production of a soluble cytotoxic factor.
    Drysdale BE; Zacharchuk CM; Shin HS
    J Immunol; 1983 Nov; 131(5):2362-7. PubMed ID: 6415164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycobacterium lepraemurium activates macrophages but fails to trigger release of superoxide anion.
    Mor N; Goren MB; Pabst MJ
    J Immunol; 1988 Jun; 140(11):3956-61. PubMed ID: 2836508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thioglycollate-elicited mouse peritoneal macrophages are less efficient than resident macrophages in antibody-dependent cell-mediated cytolysis.
    Shaw DR; Griffin FM
    J Immunol; 1982 Jan; 128(1):433-40. PubMed ID: 7054283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon.
    Titus RG; Kelso A; Louis JA
    Clin Exp Immunol; 1984 Jan; 55(1):157-65. PubMed ID: 6198115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation.
    Chensue SW; Ruth JH; Warmington K; Lincoln P; Kunkel SL
    J Immunol; 1995 Oct; 155(7):3546-51. PubMed ID: 7561051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages.
    Hatzigeorgiou DE; He S; Sobel J; Grabstein KH; Hafner A; Ho JL
    J Immunol; 1993 Oct; 151(7):3682-92. PubMed ID: 8397259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
    Howard AD; Erickson KL
    Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of macrophage lysozyme by lipopolysaccharide and interferon.
    Warfel AH; Zucker-Franklin D
    J Immunol; 1986 Jul; 137(2):651-5. PubMed ID: 2424976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
    Celada A; Gray PW; Rinderknecht E; Schreiber RD
    J Exp Med; 1984 Jul; 160(1):55-74. PubMed ID: 6330272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological functions of macrophages and their regulation by interferons.
    Virelizier JL; Arenzana-Seisdedos F
    Med Biol; 1985; 63(4):149-59. PubMed ID: 2419711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
    Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
    J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of nitric oxide produced by activated macrophages in their cytocidal activity against glial tumor cells].
    Akiyama Y; Yamasaki T; Fukuda M; Moritake K
    No To Shinkei; 1995 Apr; 47(4):349-55. PubMed ID: 7772402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
    Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
    Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.